Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.7070
-0.0143 (-1.98%)
At close: Mar 12, 2026, 4:00 PM EDT
0.7070
0.00 (0.00%)
After-hours: Mar 12, 2026, 4:10 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $22.66 million as of March 12, 2026. Its market cap has decreased by -74.16% in one year.
Market Cap
22.66M
Enterprise Value
-3.34M
1-Year Change
-74.16%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $22.66M, a decrease of -93.64%. That is a compound annual growth rate of -76.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 24.10M | 0.42% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 27.63M |
| IGC Pharma | 27.31M |
| Passage Bio | 27.30M |
| BriaCell Therapeutics | 27.09M |
| FibroBiologics | 26.77M |
| Exicure | 26.26M |
| Senti Biosciences | 26.11M |
| Boundless Bio | 25.56M |